Inijaq
Active substance: tofacitinib
tofacitinib citrate
Centralised EU authorisationActive
Marketing holder: Gedeon Richter Plc.
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 18 |
|
| US 54 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-3fbf-7b86-a708-ea6ed9d647e5,01a120c3-53a3-7047-9a10-9d3b3512f9b2,01a120c3-5b65-7613-a369-bf17c06ce903,01a120c3-645f-7d58-b16b-17be8d7ae354,01a120c3-663a-73d5-b278-bc1eab147cda;count=16 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-3db5-7a05-9bd2-ad988e5d1275,01a1208c-51b1-713d-99e1-ae49ff26c32e,01a1208c-5b27-73ba-820e-5b377cbd14ef,01a1208c-900d-70d1-bc4d-66f78f72a32c,01a1208c-b3ec-7d27-8687-eec777dcddf9;count=54 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- EMEA/H/C/006698
- Registration status
- Active
- ATC code
- L04AF01
- product · EMA · EMEA/H/C/006698 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/006698 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/006698 · Verified 2026-10-09